Lisata Therapeutics, Inc. (LSTA)
NASDAQ: LSTA · Real-Time Price · USD
2.340
-0.130 (-5.26%)
At close: Nov 5, 2025, 4:00 PM EST
2.200
-0.140 (-5.98%)
Pre-market: Nov 6, 2025, 6:25 AM EST
Lisata Therapeutics Market Cap
Lisata Therapeutics has a market cap or net worth of $20.49 million as of November 6, 2025. Its market cap has decreased by -17.05% in one year.
Market Cap
20.49M
Enterprise Value
-1.43M
1-Year Change
-17.05%
Ranking
Category
Stock Price
$2.34
Market Cap Chart
Since March 1, 1999, Lisata Therapeutics's market cap has increased from $500.00K to $20.49M, an increase of 3,997.78%. That is a compound annual growth rate of 14.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 4, 2025 | 21.60M | -13.60% |
| Dec 31, 2024 | 25.00M | 12.61% |
| Dec 29, 2023 | 22.20M | 11.56% |
| Dec 30, 2022 | 19.90M | -60.44% |
| Dec 31, 2021 | 50.30M | 81.59% |
| Dec 31, 2020 | 27.70M | 6.13% |
| Dec 31, 2019 | 26.10M | -25.43% |
| Dec 31, 2018 | 35.00M | 5.42% |
| Dec 29, 2017 | 33.20M | 43.72% |
| Dec 30, 2016 | 23.10M | -61.37% |
| Dec 31, 2015 | 59.80M | -55.61% |
| Dec 31, 2014 | 134.70M | -27.23% |
| Dec 31, 2013 | 185.10M | 93.62% |
| Dec 31, 2012 | 95.60M | 74.77% |
| Dec 30, 2011 | 54.70M | -32.64% |
| Dec 31, 2010 | 81.20M | 43.46% |
| Dec 31, 2009 | 56.60M | 1,564.71% |
| Dec 31, 2008 | 3.40M | -46.03% |
| Dec 31, 2007 | 6.30M | -57.14% |
| Dec 29, 2006 | 14.70M | 226.67% |
| Dec 30, 2005 | 4.50M | 87.50% |
| Dec 31, 2004 | 2.40M | -42.86% |
| Dec 31, 2003 | 4.20M | 366.67% |
| Dec 31, 2002 | 900.00K | -90.22% |
| Dec 31, 2001 | 9.20M | 29.58% |
View and export this data all the way back to 1999. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 843.72B |
| Johnson & Johnson | 449.96B |
| AbbVie | 378.31B |
| UnitedHealth Group | 295.92B |
| AstraZeneca | 253.45B |
| Novartis AG | 240.68B |
| Abbott Laboratories | 217.55B |
| Novo Nordisk | 215.64B |